Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Novus Biologicals™ Recombinant Human ERGI3 His Protein
SDP

Catalog No. NBP25193701 Shop All Novus Biologicals Products
Click to view available options
Quantity:
0.1 mg
0.5 mg

Highly purified. Generating reliable and reproducible results.

A recombinant protein with a N-Terminal His-tag and corresponding to the amino acids 47-341 of Human ERGI3 The Recombinant Human ERGI3 Protein is derived from E. coli. The Recombinant Human ERGI3 Protein has been validated for the following applications: SDS-Page.

Specifications

Concentration 1mg/mL
For Use With (Application) SDS-PAGE
Formulation PBS buffer (pH 7.4) containing 10% glycerol, 1mM DTT
Gene ID (Entrez) 51614
Molecular Weight (g/mol) TMW: 36.1kDa
Quantity 0.1 mg
Storage Requirements Store at 4°C short term. Aliquot and store at −20°C long term. Avoid freeze-thaw cycles.
Gene Alias C20orf47, CGI-54, chromosome 20 open reading frame 47, dJ477O4.2, endoplasmic reticulum-Golgi intermediate compartment protein 3, endoplasmic reticulum-localized protein ERp43, ERGIC and golgi 3, Erv46, NY-BR-84, PRO0989, SDBCAG84, serologically defined breast cancer antigen 84, Serologically defined breast cancer antigen NY-BR-84
Common Name ERGI3
Conjugate Unconjugated
Recombinant Recombinant
Purity or Quality Grade >95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie™ Blue stain
Show More Show Less

For research use only and is not approved for use in humans or in clinical diagnosis

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.